Literature DB >> 27022736

Interleukin-22 promotes papillary thyroid cancer cell migration and invasion through microRNA-595/Sox17 axis.

Zhidan Mei1, Li Zhou2, Youhua Zhu1, Kejia Jie1, Daqing Fan1, Jian Chen1, Xiguo Liu1, Liang Jiang1, Qike Jia1, Wei Li3.   

Abstract

Interleukin-22 (IL-22) is an inflammatory cytokine mainly produced by activated Th17 and Th22 cells. The data presented here demonstrate that IL-22 induced the migration and invasion of papillary thyroid cancer (PTC) cells. MicroRNA expression analysis and functional studies indicated that IL-22-mediated migration and invasion is positively regulated by miR-595. Further mechanistic studies revealed that sex-determining region Y-box 17 (Sox17) is directly targeted by miR-595. We then demonstrated that IL-22 regulated migration and invasion of PTC cells via inhibiting Sox17 expression. Interestingly, in PTC cell lines and PTC tissues, expression of IL-22 and miR-595 was upregulated and Sox17 downregulated compared with normal thyroid, and their expression levels were closely correlated. Taken together, this present study suggests that IL-22 stimulation enhances the migration and invasion of PTC cells by regulating miR-595 and its target Sox17.

Entities:  

Keywords:  Interleukin-22; Invasion; Migration; Papillary thyroid cancer; Sox17; miR-595

Mesh:

Substances:

Year:  2016        PMID: 27022736     DOI: 10.1007/s13277-016-5030-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  30 in total

1.  Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes.

Authors:  S V Kotenko; L S Izotova; O V Mirochnitchenko; E Esterova; H Dickensheets; R P Donnelly; S Pestka
Journal:  J Biol Chem       Date:  2000-10-16       Impact factor: 5.157

2.  World Health Organization classification of tumours: pathology and genetics of head and neck tumours.

Authors:  Lester Thompson
Journal:  Ear Nose Throat J       Date:  2006-02       Impact factor: 1.697

3.  Sox17 regulates proliferation and cell cycle during gastric cancer progression.

Authors:  Yan-Wei Ye; Jiang-Hong Wu; Chun-Meng Wang; Ye Zhou; Chun-Yan Du; Bi-Qiang Zheng; Xi Cao; Xiao-Yan Zhou; Meng-Hong Sun; Ying-Qiang Shi
Journal:  Cancer Lett       Date:  2011-04-22       Impact factor: 8.679

4.  An analysis of factors predicting lateral cervical nodal metastases in papillary carcinoma of the thyroid.

Authors:  Jason P Hunt; Luke O Buchmann; Libo Wang; Dev Abraham
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2011-11

Review 5.  Recent advances in IL-22 biology.

Authors:  Lauren A Zenewicz; Richard A Flavell
Journal:  Int Immunol       Date:  2011-03       Impact factor: 4.823

6.  Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.

Authors:  Weici Zhang; Yongyan Chen; Haiming Wei; Chaogu Zheng; Rui Sun; Jian Zhang; Zhigang Tian
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

Review 7.  Management of medullary thyroid carcinoma.

Authors:  Camilo Jiménez; Mimi I-Nan Hu; Robert F Gagel
Journal:  Endocrinol Metab Clin North Am       Date:  2008-06       Impact factor: 4.741

8.  Current management of medullary thyroid cancer.

Authors:  Rebecca S Sippel; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Oncologist       Date:  2008-05

9.  IL-22 increases the innate immunity of tissues.

Authors:  Kerstin Wolk; Stefanie Kunz; Ellen Witte; Markus Friedrich; Khusru Asadullah; Robert Sabat
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

10.  Sox17 regulates insulin secretion in the normal and pathologic mouse β cell.

Authors:  Diva Jonatan; Jason R Spence; Anna M Method; Matthew Kofron; Katie Sinagoga; Leena Haataja; Peter Arvan; Gail H Deutsch; James M Wells
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

View more
  8 in total

1.  Expression Profile and Diagnostic Significance of MicroRNAs in Papillary Thyroid Cancer.

Authors:  Mariusz Rogucki; Iwona Sidorkiewicz; Magdalena Niemira; Janusz Bogdan Dzięcioł; Angelika Buczyńska; Agnieszka Adamska; Katarzyna Siewko; Maria Kościuszko; Katarzyna Maliszewska; Anna Wójcicka; Jakub Supronik; Małgorzata Szelachowska; Joanna Reszeć; Adam Jacek Krętowski; Anna Popławska-Kita
Journal:  Cancers (Basel)       Date:  2022-05-28       Impact factor: 6.575

Review 2.  MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.

Authors:  Amir Abbas Hamidi; Negin Taghehchian; Zahra Basirat; Amir Sadra Zangouei; Meysam Moghbeli
Journal:  Biomark Res       Date:  2022-06-04

3.  Oncogenic role of Tc17 cells in cervical cancer development.

Authors:  Zun-Sheng Zhang; Ying Gu; Bing-Gang Liu; Hong Tang; Yu Hua; Jun Wang
Journal:  World J Clin Cases       Date:  2020-01-06       Impact factor: 1.337

4.  circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway.

Authors:  Shifan Zhou; Zhizhong Guo; Chaofeng Zhou; Yu Zhang; Sai Wang
Journal:  Cancer Cell Int       Date:  2021-05-06       Impact factor: 5.722

Review 5.  MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment.

Authors:  Maria Papaioannou; Angeliki G Chorti; Anthoula Chatzikyriakidou; Kleanthis Giannoulis; Sohail Bakkar; Theodosios S Papavramidis
Journal:  Front Oncol       Date:  2022-02-03       Impact factor: 6.244

Review 6.  Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice.

Authors:  Chuang Xi; Guo-Qiang Zhang; Zhen-Kui Sun; Hong-Jun Song; Chen-Tian Shen; Xiao-Yue Chen; Jian-Wen Sun; Zhong-Ling Qiu; Quan-Yong Luo
Journal:  Front Immunol       Date:  2020-06-12       Impact factor: 7.561

7.  MicroRNA‑21‑5p promotes epithelial to mesenchymal transition by targeting SRY‑box 17 in endometrial cancer.

Authors:  Cuilan Wang; Qing Li; Yuan He
Journal:  Oncol Rep       Date:  2020-03-20       Impact factor: 3.906

8.  TRIM30 modulates Interleukin-22-regulated papillary thyroid Cancer cell migration and invasion by targeting Sox17 for K48-linked Polyubiquitination.

Authors:  Wei Li; Fen Li; Weiwei Lei; Zezhang Tao
Journal:  Cell Commun Signal       Date:  2019-12-10       Impact factor: 5.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.